Alternative Polyadenylation and Its Impact on Cellular Processes
Journal:
MicroRNA
Volume:
3
Page:
2-9
Author(s):
Hesna B. Akman and Ayse E. Erson-Bensan
Mitochondrial Involvement in Psychiatric Illness in Adults
Journal:
Current Psychiatry Reviews
Volume:
10
Page:
192-199
Author(s):
Rebecca E.S. Anglin, Mark A. Tarnopolsky, Michael F. Mazurek and Patricia I. Rosebush
Regulation of miRNA Processing and miRNA Mediated Gene Repression in Cancer
Journal:
MicroRNA
Volume:
3
Page:
10-17
Author(s):
Sarah Bajan and Gyorgy Hutvagner
Editorial (Thematic Issue: Helicobacter pylori Eradication Therapy: Advantages and Disadvantages)
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
4487-4488
Author(s):
Justyna Bien, Maria Bozko, Nisar P. Malek and Przemyslaw Bozko
Population Based Helicobacter pylori Screening and Eradication: Advances Versus Side Effects
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
4501-4509
Author(s):
Prof Bojan Tepes
Strategy for the Treatment of Helicobacter pylori Infection
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
4489-4500
Author(s):
Seiji Shiota and Yoshio Yamaoka
Choosing Optimal Firstline Helicobacter pylori Therapy: a View from a Region with High Rates of Antibiotic Resistance
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
4510-4516
Author(s):
Alexander A. Nijevitch, Bulat Idrisov, Elsa N. Akhmadeeva and David Y. Graham
Is Helicobacter pylori Always a "Bad Guy"?
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
4517-4520
Author(s):
Iva Hojsak and Sanja Kolacek
Current and Future Insights in H. pylori Eradication Regimens: The Need of Tailoring Therapy
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
4521-4532
Author(s):
Vasilios Papastergiou, Sotirios D. Georgopoulos and Stylianos Karatapanis
α-Synuclein Ubiquitination and Novel Therapeutic Targets for Parkinson's Disease
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
13
Page:
630-637
Author(s):
Ruth Rott, Raymonde Szargel, Vered Shani, Sleman Bisharat and Simone Engelender